A Versatile and Efficient Novel Approach for Mendelian Randomization Analysis with Application to Assess the Causal Effect of Fetal Hemoglobin on Anemia in Sickle Cell Anemia

نویسندگان

چکیده

Mendelian randomization (MR) is increasingly employed as a technique to assess the causation of risk factor on an outcome using observational data. The two-stage least-squares (2SLS) procedure commonly used examine genetic variants instrument variables. validity 2SLS relies representative sample randomly selected from study cohort or population for genome-wide association (GWAS), which not always true in practice. For example, extreme phenotype sequencing (EPS) design widely investigate determinants GWAS it bears many advantages such efficiency, low genotyping cost, and large power detecting involvement rare disease etiology. In this paper, we develop novel, versatile, efficient approach, namely MR analysis under Extreme random Phenotype Sampling (MREPS), one-sample based samples drawn through either sampling nonrandom EPS design. simulations, MREPS provides unbiased estimates causal effects, correct type I errors effect testing. Furthermore, robust different designs has high power. These results demonstrate superiority over standard approach. We applied highlight total fetal hemoglobin anemia patients with sickle cell two independent studies. A user-friendly Shiny app web interface was implemented professionals easily explore MREPS.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Effect of Amelioration of Anemia on the Synthesis of Fetal Hemoglobin in Sickle Cell Anemia.

By L. JUDEN REED, THOMAS B. BRADLEY, JR. AND HEu N M. RANNEY F ETAL HEMOGLOBIN, a tetramer of 2a and 2y polypeptide chains, constitutes the major hemoglobin component in newborn infants. During the first 6 months of extra-uterine life, the synthesis of y chains declines as chain synthesis increases. Adult Hb A, a tetramer of 2a and 2$ polypeptide chain accounts for over 95 per cent of the hemog...

متن کامل

Fetal hemoglobin in sickle cell anemia

Fetal hemoglobin (HbF) is the major genetic modulator of the hematologic and clinical features of sickle cell disease, an effect mediated by its exclusion from the sickle hemoglobin polymer. Fetal hemoglobin genes are genetically regulated, and the level of HbF and its distribution among sickle erythrocytes is highly variable. Some patients with sickle cell disease have exceptionally high level...

متن کامل

Fetal hemoglobin in sickle cell anemia: a glass half full?

Fetal hemoglobin (HbF) modulates the phenotype of sickle cell anemia by inhibiting deoxy sickle hemoglobin (HbS) polymerization. The blood concentration of HbF, or the number of cells with detectable HbF (F-cells), does not measure the amount of HbF/F-cell. Even patients with high HbF can have severe disease because HbF is unevenly distributed among F-cells, and some cells might have insufficie...

متن کامل

Fetal hemoglobin and hemolysis markers in sickle cell anemia☆

It has been known for many years that high levels of fetal hemoglobin (Hb F) have an important clinical benefit in patients with sickle cell anemia (SCA). This knowledge was initially based on the observation that populations of Indian and Arabian SCA patients with high Hb F levels have a milder clinical form of the disease.1 Later on, epidemiological studies demonstrated that patients with Hb ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Mathematics

سال: 2022

ISSN: ['2227-7390']

DOI: https://doi.org/10.3390/math10203743